Shuttle Pharmaceuticals Holdings, Inc.
SHPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $4 | $4 | $1 | $1 |
| G&A Expenses | $4 | $2 | $0 | $1 |
| SG&A Expenses | $4 | $2 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$0 |
| Operating Expenses | $8 | $6 | $2 | $2 |
| Operating Income | -$8 | -$6 | -$2 | -$2 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$1 | -$1 | -$3 | $1 |
| Pre-Tax Income | -$9 | -$7 | -$5 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$9 | -$7 | -$5 | -$1 |
| % Margin | – | – | – | – |
| EPS | -885.73 | -0.41 | -0.3 | -0.095 |
| % Growth | -215,931.7% | -36.7% | -217.5% | – |
| EPS Diluted | -885.73 | -0.41 | -0.3 | -0.095 |
| Weighted Avg Shares Out | 10 | 16 | 10 | 14 |
| Weighted Avg Shares Out Dil | 10 | 16 | 10 | 14 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $3 | $1 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$8 | -$4 | -$4 | -$1 |
| % Margin | – | – | – | – |